Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-30

FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Atenolol submitted by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)

Snippet

SUPPL AP for ATENOLOL (ATENOLOL)